CD34 and Schnyder corneal dystrophy: In this study, we used the previously characterized γ-globin lentiviral vector GGHI [32] and the novel optimized GGHI-mB-3D [38], both successfully assessed using thalassemic CD34+ cells [32,38], and investigated whether they can also improve or correct the SCD phenotype in vitro.